How to analyze the company?LEARNWhat should you know before buying?
Get a brief AI stock analysisSaves ~ 15 minutes of your time

FE

NASDAQ:FENC
Get a brief AI stock analysisSaves ~ 15 minutes of your time

FE

Fennec Pharmaceuticals IncNASDAQ FENC Stock Report

Get a brief AI stock analysis
Saves ~ 15 minutes of your time

Price

Market cap $B

Exchange

XNAS - Nasdaq

FAIR VALUE

Is FENC undervalued compared to its fair value?

The fair value of FENC stock is hidden USD. Relative to the market price of 6.39 USD Fennec Pharmaceuticals Inc is hidden.

Fennec Pharmaceuticals, Inc. operates as a biopharmaceutical company. The company is headquartered in Research Triangle Park, North Carolina and currently employs 10 full-time employees. The company went IPO on 2001-06-0...[More about valuation]

Fennec Pharmaceuticals Fair Value

hidden
UNLOCK
What is fair value?

Market cap:

0.173 $B

Price:

6.39 USD

Fair value:

hidden

Max value:

hidden

Min value:

hidden

P/E:

hidden

EPS:

0.413

FINANCIALS

Fennec Pharmaceuticals financial for reporting period

Income Statement

0.025 B N/A

Growth Rates:
1 yearN/A
3 yearsN/A
5 yearsN/A
0.014 B N/A

Growth Rates:
1 yearN/A
3 yearsN/A
5 yearsN/A
0.013 B N/A

Growth Rates:
1 yearN/A
3 yearsN/A
5 yearsN/A
Revenue analysis

0.025 B 100%
0.025 B 98%
0.013 B 51%

Balance Sheet

0.069 B
0.003 B


Financial Position Analysis

Assets

0.069 B
Current Assets
0.068 B
Total non-current assets
0.001 B

Total current liabilities
0.0098 B
Total non-current liabilities
0.056 B

Cash Flow Statement

-0.014 B N/A

Growth Rates:
1 yearN/A
3 yearsN/A
5 yearsN/A
0.013 B N/A

Growth Rates:
1 yearN/A
3 yearsN/A
5 yearsN/A

Fennec Pharmaceuticals fundamental analysis for trailing twelve months (TTM)

Profitability Indicators


Average:
1 yearundefined%
3 yearsundefined%
5 yearsundefined%

Average:
1 yearundefined%
3 yearsundefined%
5 yearsundefined%

Average:
1 yearundefined%
3 yearsundefined%
5 yearsundefined%

Average:
1 yearundefined%
3 yearsundefined%
5 yearsundefined%

Solvency Indicators


Average:
1 yearundefined%
3 yearsundefined%
5 yearsundefined%

Average:
1 yearundefined%
3 yearsundefined%
5 yearsundefined%

Average:
1 yearundefined%
3 yearsundefined%
5 yearsundefined%

Efficiency Indicators


Average:
1 yearundefined%
3 yearsundefined%
5 yearsundefined%
118 %

Average:
1 yearundefined%
3 yearsundefined%
5 yearsundefined%
8 %

Average:
1 yearundefined%
3 yearsundefined%
5 yearsundefined%

Average:
1 yearundefined%
3 yearsundefined%
5 yearsundefined%

Dupont Analysis

Stability Indicators

STOCK ANALYSIS

Is FENC attractive for investment based on fundamental analysis?

FENC stock rating is hidden. Fennec Pharmaceuticals is a hidden by Eyestock methodology.

Get FENC Stock Rating
to complete you analysis
UNLOCK
Learn more about quality score?

Net Profit Margin:

6

Gross Margin:

96

CFO / Debt ratio:

hidden

Current ratio:

5.316

Debt / Equity ratio:

ROE:

ROIC:

hidden

Stability Ratio (2y):

hidden

Stability Ratio (5y):

hidden

Earnings quality:

hidden

FENC analysis by AI

Eyebot AI analysis

We carefully consider 10 indicators for FENC to calculate the final rating score. Use AI leverage to quickly get the main conclusions before diving into the details

Fennec Pharmaceuticals Inc competitors

AB

ABBV

Abbvie Inc

AbbVie, Inc. is a research-based biopharmaceutical company, which engages in the development and sale of pharmaceutical products. The company is headquartered in North Chicago, Ill...

Discover

AM

AMGN

Amgen Inc

Amgen Inc. is a biotechnology company. The Company discovers, develops, manufactures and delivers various human therapeutics. It operates in human therapeutics segment. The Company...

Discover

VR

VRTX

Vertex Pharmaceuticals Inc

Vertex Pharmaceuticals, Inc. is a global biotechnology company, which engages in the business of discovering, developing, manufacturing, and commercializing small molecule drugs fo...

Discover

Fennec Pharmaceuticals Inc dividends

FENC dividend metrics

Payout ratio
Dividend yield
Annual dividend
Dividend streak
Average dividend yield over 3 years
Average dividend yield over 5 years

Dividend per share

By years
By payments
1y
3y
5y
All time
This ticker has no dividend history

About FENC stock

About the company Fennec Pharmaceuticals Inc

Market cap $B

0.173

Dividend yield

Shares outstanding

26.2606 B

Fennec Pharmaceuticals, Inc. operates as a biopharmaceutical company. The company is headquartered in Research Triangle Park, North Carolina and currently employs 10 full-time employees. The company went IPO on 2001-06-05. The firm is focused on the development of PEDMARK for the prevention of platinum-induced ototoxicity in pediatric cancer patients. The Company’s only product candidate in the clinical-stage of development is PEDMARK. The company announced two results of Phase III clinical trials for the prevention of cisplatin induced hearing loss, or ototoxicity in children, including the pivotal Phase III study SIOPEL 6 and the proof-of-concept Phase III study in collaboration with the Children’s Oncology Group (COG ACCL0431). PEDMARK has the potential to reduce the incidence and/or grade of chemotherapy-induced hearing loss. The Company’s four subsidiaries includes Oxiquant, Inc. and Fennec Pharmaceuticals, Inc., both Delaware corporations, Cadherin Biomedical Inc., a Canadian company, and Fennec Pharmaceuticals (EU) Limited (Fennec Limited), an Ireland company. Apart from Fennec Pharmaceuticals, Inc., all subsidiaries are inactive.

FENC profile

  • Ticker

    FENC

  • Country

    USA

  • Exchange

    XNAS - Nasdaq

  • Report currency

    USD - US dollar

  • IPO date

    05 June 2001

  • Sector

    Healthсare

  • Industry

    Biotechnology

  • Employees

    10

  • City

    RESEARCH TRIANGLE PARK

  • Address

    PO Box 13628, 68 Tw Alexander Dr

  • Cusip

    31447P100